Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Effectiveness of Spironolactone to Reduce Proteinuria in Kidney Transplant Recipients During a 5-Year Follow-Up.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same author

Pregnancy Outcomes Among Women With Kidney Allografts in Brazil: An Integrative Review.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same author

Promoting Equity in Transplant Research by Addressing the Exclusion of Patients With Glomerular Disease.

Kidney international reports·2025
Same author

Association between carotid sublayers thickness and cardiac alterations in dialysis patients.

Current medical research and opinion·2025
Same author

Genetic Variability in Cisplatin Metabolism in Kidney Injury in Patients With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiotherapy.

Head & neck·2025
Same author

Segmental and Focal Glomerulosclerosis Secondary to MELAS Syndrome and Long-Term Outcomes After Kidney Transplant: Case Report and Literature Review.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2025

Related Experiment Video

Updated: May 28, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Uric acid and transplantation.

Fernanda Cristina Mazali1, Marilda Mazzali

  • 1Division of Nephrology, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, UNICAMP, Campinas, São Paulo, Brazil.

Seminars in Nephrology
|October 18, 2011
PubMed
Summary

Post-transplant hyperuricemia is common, especially in kidney and heart recipients. Its impact on patient and graft survival is still being investigated, with ongoing debate about whether it causes or merely indicates chronic allograft dysfunction.

Area of Science:

  • Nephrology
  • Immunology
  • Cardiology

Background:

  • Hyperuricemia frequently complicates organ transplantation, particularly in kidney and heart recipients.
  • Identified risk factors include decreased kidney function, diuretic use, cyclosporine, older age, obesity, metabolic syndrome, and pre-existing hyperuricemia.

Purpose of the Study:

  • To review the incidence and risk factors of post-transplant hyperuricemia.
  • To examine the influence of immunosuppressive drugs on uric acid levels.
  • To explore the relationship between uric acid and chronic allograft dysfunction.

Main Methods:

  • Literature review of studies on post-transplant hyperuricemia.
  • Analysis of risk factors and their association with outcomes.
  • Comparison of uric acid levels and renal function in transplant recipients.

More Related Videos

Murine Renal Transplantation Procedure
18:48

Murine Renal Transplantation Procedure

Published on: July 10, 2009

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

Related Experiment Videos

Last Updated: May 28, 2026

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation
08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Murine Renal Transplantation Procedure
18:48

Murine Renal Transplantation Procedure

Published on: July 10, 2009

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

Main Results:

  • Hyperuricemia incidence and risk factors are well-defined.
  • The causal role of uric acid in chronic allograft dysfunction remains debated.
  • Uric acid's impact on patient and graft survival requires further investigation.

Conclusions:

  • Hyperuricemia is a significant concern in organ transplant recipients.
  • Further research is needed to clarify the direct impact of uric acid on graft survival and function.
  • Management strategies may involve adjusting immunosuppression and lifestyle modifications.